News Conference News ACC 2017 Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE L.A. McKeown March 18, 2017
News Conference News ACC 2017 SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients Todd Neale March 17, 2017
News Conference News ACC 2016 New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands Shelley Wood April 12, 2016
News Conference News ACC 2016 CT Angiography and Stress Testing: Prognostic Value Differs Between Women and Men Caitlin E. Cox April 08, 2016
News Conference News ACC 2016 Cardioband Transcatheter Mitral Annulus Repair Appears Safe, Effective in Functional MR Shelley Wood April 07, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
News Conference News ACC 2016 Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon Michael O'Riordan April 06, 2016
News Conference News ACC 2016 Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure Todd Neale April 05, 2016
News Conference News ACC 2016 DANAMI3: Deferred Stenting, Ischemic Postconditioning No Help in STEMI Todd Neale April 04, 2016
News Conference News ACC 2016 ‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study Michael O'Riordan April 04, 2016
News Conference News ACC 2016 Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices L.A. McKeown April 03, 2016
News Conference News ACC 2016 When Chosen Wisely, 90-Year-Olds Do Well After TAVR Caitlin E. Cox April 02, 2016
News Conference News ACC 2015 Small Study Suggests Benefits of Denervation for Pulmonary Arterial Hypertension Todd Neale March 17, 2015
News Conference News ACC 2015 SCOT-HEART Provides Support for Coronary CTA in Angina Management L.A. McKeown March 15, 2015
Presentation ACC 2015 Clinical and Echocardiographic Outcomes at 30 Days with the SAPIEN 3 TAVR System in Inoperable, High-Risk and Intermediate-Risk AS Patients Presenter: Susheel K. Kodali March 15, 2015
News Conference News ACC 2015 Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR Yael L. Maxwell March 15, 2015
News Conference News ACC 2015 Follow-up TAVR Studies Reassure About Valve Durability, Outcomes Todd Neale March 15, 2015
News Conference News ACC 2015 Coronary CTA Fails to Live Up to Its PROMISE in Suspected CAD L.A. McKeown March 14, 2015
News Conference News ACC 2014 CHOICE Trial, TVT Registry Shed Light on Evolving TAVR Outcomes, Risks L.A. McKeown March 31, 2014
News Conference News ACC 2014 TAV-in-BAV: TAVR Achieves Positive Outcomes In Bicuspid Aortic Valve Disease Jason Kahn March 30, 2014